Skip to content

Early Cardiac Computed Tomography (CT) In Patients Admitted With Acute Chest Pain

The Role of Early X-Ray Cardiac Computed Tomography in Patients Admitted With Acute Chest Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00767065
Acronym
EXACCT
Enrollment
250
Registered
2008-10-06
Start date
2009-01-31
Completion date
2011-12-31
Last updated
2008-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Chest Pain

Brief summary

This is a randomised trial comparing early Cardiac Computed Tomography (CCT) to current standard practice for diagnosis of acute chest pain in patients at low to intermediate risk of having coronary artery disease (CAD), in a UK setting. We hypothesise that early CCT can reduce length of admission, reduce NHS costs and improve quality of life whilst being at least as safe as standard practice.

Detailed description

Coronary Artery Disease (CAD) kills more people in the UK than any other condition, and causes symptoms of angina (chest pain) in many more. Acute chest pain accounts for approximately 600,000 NHS admissions per annum, but this includes many other types of chest pain not due to heart problems. Examination, blood tests and an electrocardiogram (ECG) are used to try and decide the cause of chest pain. Many patients have a low risk of CAD and can be discharged without further investigation. Others are at high risk of CAD and must have further tests such as invasive coronary angiography. Unfortunately in many patients the initial tests are equivocal and they are felt to have an intermediate probability of CAD. Investigation of symptoms in this group may take place in the in-patient setting, warranting a hospital stay of several days, or alternatively some investigations may be performed as an out-patient with subsequent time spent on waiting lists. This results in extensive use of NHS resources and anxiety for the patients whilst awaiting diagnosis, often needlessly as approximately half of patients admitted with acute chest pain are eventually discharged without a cardiac cause found. The new technique of cardiac computed tomography (CCT) offers rapid non-invasive diagnosis of CAD. If disease is detected further investigations can be planned; when excluded, patients may be safely discharged. Detection of clinically insignificant disease will initiate primary preventative strategies but excludes CAD as the cause of acute symptoms. We will randomise 250 patients presenting to Chelsea and Westminster Hospital with acute chest pain who have intermediate likelihood of CAD to early CCT or current standard practice. We hypothesise that, when compared to standard practice, early CCT will reduce admission length, reduce NHS and other costs and improve quality of life without an increase in adverse events.

Interventions

Patients randomised to the CCT arm will undergo 128-channel cardiac computed tomography with delayed acquisition. Patients will receive beta-blockade if necessary prior to the scan to achieve a heart rate of less than 70/min. An unenhanced scan will be performed in all patients to assess coronary artery calcium score. Patients will then undergo contrast enhanced CCT. After a bolus tracking acquisition, injection of 120mls iodinated contrast at 5ml/s will be followed by 40ml normal saline/contrast (in 50:50 proportion), also at 5ml/s. Imaging will be performed with a gated cardiac CT protocol. Where possible (stable rhythm and heart rate \<70bpm) a low dose technique will be utilised. When not possible a retrospective gating method will be employed. In the latter case the ECG will be used to assign the images to their respective phases of the cardiac cycle. 10 minutes after contrast injection, a second prospectively gated scan will be acquired to assess myocardial enhancement patterns.

OTHERStandard care

Further investigations as decided by the patient's clinical team, according to best normal practice. These may include some or all of: further blood tests, exercise stress testing and myocardial perfusion scintigraphy. These may be conducted either during the initial hospital admission, or subsequently as an outpatient.

Sponsors

Royal Brompton & Harefield NHS Foundation Trust
CollaboratorOTHER
British Heart Foundation
CollaboratorOTHER
Chelsea and Westminster NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Admission with suspected cardiac chest pain 2. \>40 years of age 3. EITHER Low likelihood of CAD according to DFC and troponin\>0.03 but \<3 OR Intermediate likelihood of CAD according to DFC 4. Written informed consent

Exclusion criteria

1. ECG consistent with acute myocardial infarction (ST elevation, new left bundle branch block) 2. Ongoing chest pain with dynamic ECG changes 3. Haemodynamic or respiratory instability 4. Serum troponin ≥3 5. Previous percutaneous coronary intervention or coronary artery bypass grafting 6. Admission to hospital between 5pm Friday and 9am Sunday 7. Contraindication to negative chronotropic agents 8. Maximum heart rate \>70bpm (including after pharmacologic treatment) 9. Renal dysfunction (Creat\>150 micromol/l) 10. Pregnancy or childbearing potential 11. Allergy or previous intolerance of iodinated contrast

Design outcomes

Primary

MeasureTime frame
Length of hospital admissionAt the end of initial hospital admission

Secondary

MeasureTime frame
NHS costs and cost-effectiveness over a one-year periodOne year
Patient quality of life at 1, 6 and 12 months after admission1 year
Patient anxiety about symptoms 1, 6 and 12 months after admission1 year
The incidence of major adverse cardiovascular events (MACE) over a one year period.1 year

Countries

United Kingdom

Contacts

Primary ContactSimon Padley, MB BS BSc FRCP FRCR
s.padley@ic.ac.uk(0044) 020 8746 8000
Backup ContactJim Stirrup, MB BS BSc MRCP
j.stirrup@rbht.nhs.uk(0044) 020 7352 8121

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026